- Home
- ENSC vs XWEL Comparison
ENSC vs XWEL Comparison
Compare ENSC & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- XWEL
- Stock Information
- Founded
- ENSC 2003
- XWEL 2006
- Country
- ENSC United States
- XWEL United States
- Employees
- ENSC N/A
- XWEL N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- ENSC Health Care
- XWEL Consumer Discretionary
- Exchange
- ENSC Nasdaq
- XWEL Nasdaq
- Market Cap
- ENSC 9.8M
- XWEL 9.0M
- IPO Year
- ENSC N/A
- XWEL N/A
- Fundamental
- Price
- ENSC $7.77
- XWEL $1.25
- Analyst Decision
- ENSC
- XWEL
- Analyst Count
- ENSC 0
- XWEL 0
- Target Price
- ENSC N/A
- XWEL N/A
- AVG Volume (30 Days)
- ENSC 100.5K
- XWEL 49.5K
- Earning Date
- ENSC 03-14-2025
- XWEL 11-14-2024
- Dividend Yield
- ENSC N/A
- XWEL N/A
- EPS Growth
- ENSC N/A
- XWEL N/A
- EPS
- ENSC N/A
- XWEL N/A
- Revenue
- ENSC $4,421,404.00
- XWEL $33,833,000.00
- Revenue This Year
- ENSC $89.78
- XWEL $22.75
- Revenue Next Year
- ENSC N/A
- XWEL N/A
- P/E Ratio
- ENSC N/A
- XWEL N/A
- Revenue Growth
- ENSC 40.41
- XWEL 11.79
- 52 Week Low
- ENSC $2.12
- XWEL $1.15
- 52 Week High
- ENSC $30.90
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- ENSC 50.09
- XWEL 38.69
- Support Level
- ENSC $6.75
- XWEL $1.15
- Resistance Level
- ENSC $9.57
- XWEL $1.62
- Average True Range (ATR)
- ENSC 0.73
- XWEL 0.13
- MACD
- ENSC -0.13
- XWEL -0.03
- Stochastic Oscillator
- ENSC 36.17
- XWEL 18.52
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.